SprintRay launched Midas Restore, an FDA-cleared ceramic-zirconia 3D-printed restorative material, on September 1, 2026 — delivering same-visit definitive crowns, inlays, onlays, and veneers with flexural strength up to 215 MPa and no furnace or glazing required. As of September 2026, the dental 3D printing segment is expanding rapidly, with the global dental equipment market projected to reach $28.15 billion this year.
As of September 2026, the dental 3D printing landscape is experiencing a significant inflection point. Materials that were once limited to provisional restorations and surgical guides are now entering the definitive restorative space — meaning the crown a patient leaves with could be designed, printed, finished, and cemented in a single appointment. For Canadian dental practices evaluating digital workflow investments, the implications are substantial.
SprintRay Midas Restore: What the Numbers Say
SprintRay, the Los Angeles-based dental 3D printing company, began shipping Midas Restore across the United States on September 1, 2026. The material received FDA 510(k) clearance (K260661) as a Class II medical device, and it represents what SprintRay describes as a new category of highly filled printable restoratives designed exclusively for the Midas Digital Press platform.
The technical specifications are worth examining in detail. Midas Restore is a glass ceramic and zirconia-filled resin with over 75% filler content by weight. Its mean biaxial flexural strength reaches 180 MPa, with a maximum recorded value of 215 MPa under ISO 6872 testing — the highest of any SprintRay definitive restorative material to date. Surface hardness exceeds 80 HV, and after 5,000 simulated toothbrush abrasion cycles, 98% of the original gloss remained intact.
Pro Tip: When evaluating printable restorative materials, compare flexural modulus alongside flexural strength. SprintRay positions Midas Restore's flexural modulus closer to natural dentin than glass ceramic, which may reduce stress concentration at the tooth-restoration interface during function.
In internal wear testing involving more than 200,000 loading cycles, SprintRay reports that Midas Restore achieved five times the wear resistance of its predecessor Ceramic Crown material — comparable to milled hybrid ceramic. Translucency is measured at 13.5 (Shade A1), a parameter SprintRay says is comparable to milled lithium disilicate HT.
The Same-Visit Workflow in Practice
What makes the Midas Restore announcement clinically relevant is the workflow simplification. After printing, the material requires a four-minute post-cure cycle and under two minutes of mechanical polishing with two wheels. No glaze coat is applied. No furnace firing is needed. Multiple units can be produced from a single capsule, and the material can be adjusted, added to, and repaired intraorally before cementation.
The material ships in five Vita-classic shades — A1, A2, A3, B1, and C2 — at a price point of $135 USD for a three-pack of single-unit capsules through SprintRay's store and authorized distributors.
Why This Matters for Canadian Practices
Canadian dental professionals watching the 3D printing space should note several contextual factors. First, the global dental equipment market is expected to grow 9.8% year over year to $28.15 billion in 2026, with 3D printing identified as one of the fastest-growing segments. Projections show the market accelerating to $42.38 billion by 2030.
Second, the clinical adoption barrier for chairside 3D printing has historically been the gap between provisional and definitive materials. Printing a surgical guide or a temporary crown is now routine. Printing a restoration that a patient wears permanently — with mechanical properties and aesthetics comparable to milled alternatives — has been the missing link. SprintRay's entry into this space, with published flexural and wear data, signals that the material science is catching up to the hardware.
Third, the economics of chairside 3D printing deserve scrutiny. At $135 USD for three single-unit capsules ($45 USD per unit in material cost), the per-unit material cost is substantially lower than traditional lab fees for a PFM or zirconia crown. However, Canadian practices must factor in equipment acquisition costs for the Midas Digital Press and NanoCure system, staff training time, and the learning curve associated with any new digital workflow.
Pro Tip: Before investing in chairside 3D printing, calculate your practice's crown volume per month. Most industry analysts suggest a breakeven point around 15 to 20 units per month for a fully utilized system. Below that threshold, partnering with a digital lab that offers fast turnaround may be more economical.
The Broader 3D Printing Trend in Dentistry
SprintRay's announcement does not exist in isolation. The dental 3D printing ecosystem is maturing across multiple fronts. Earlier in 2026, researchers at UT Dallas published a breakthrough method for 3D printing zirconia crowns that cuts traditional processing time by 99% — potentially enabling same-day monolithic zirconia restorations in the future. EMS also marked its 45th anniversary of PIEZON technology in September 2026, underscoring the pace of dental instrument evolution.
Printable resins and ceramics are becoming durable and aesthetic enough for permanent use, with smaller, faster, and more reliable printers allowing dentists to oversee every stage of production. The trend toward open, cloud-based platforms is enabling different systems — scanners, design software, printers, and practice management tools — to exchange data more freely.
For Canadian practices, the question is no longer whether digital manufacturing will transform restorative workflows, but how quickly the regulatory and distribution infrastructure will bring these materials north of the border. Health Canada classifies most dental restorative materials as Class II medical devices, requiring a Medical Device Licence for sale in Canada. Practices interested in Midas Restore should confirm Health Canada licensing status before purchasing through Canadian distributors.
What to Watch Next
The second half of 2026 will be worth monitoring closely for dental professionals evaluating their digital investment strategy. Key developments to track include:
- Canadian regulatory clearance timelines for recently FDA-cleared dental 3D printing materials, including Midas Restore
- UT Dallas zirconia printing research moving from laboratory to clinical feasibility studies
- Formnext 2026 in Frankfurt (November), where dental additive manufacturing innovations are typically debuted
- Competitive material launches from other 3D printing manufacturers seeking parity with SprintRay's published flexural and wear data
Pro Tip: Canadian dentists attending dental conferences in late 2026 should request live print demonstrations and ask specifically about ISO 6872 test data for any definitive restorative material being marketed. Published flexural strength values should always be evaluated alongside methodology — mean versus maximum values can differ significantly.
Frequently Asked Questions
Q: Can dental 3D printers produce permanent crowns that patients wear long-term?
Yes, as of September 2026, FDA-cleared materials like SprintRay Midas Restore are designed for definitive restorations including crowns, inlays, onlays, and veneers. These materials achieve flexural strengths up to 215 MPa and demonstrate wear resistance comparable to milled hybrid ceramics in published testing.
Q: How much does a 3D-printed dental crown cost compared to a traditional lab crown?
Material cost for a 3D-printed chairside crown using Midas Restore is approximately $45 USD per unit. Traditional lab-fabricated crowns typically cost practices between $100 and $250 CAD depending on the material and laboratory. However, chairside printing requires capital equipment investment and staff training that must be factored into the total cost analysis.
Q: Are 3D-printed dental restorations available in Canada?
Dental 3D printers and provisional printing materials are available in Canada. For newer definitive restorative materials like Midas Restore, Canadian practices should confirm Health Canada Medical Device Licence status before purchasing, as FDA clearance in the United States does not automatically extend to Canada.